OptimumBank Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that OptimumBank Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.65M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $13.12M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $6.28M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $4.02M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $6.30M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($782.0K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | ($1.10M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $796.0K | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | ($589.0K) | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | ($396.0K) | Mar 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $932.93M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $791.25M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $585.22M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $351.88M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $235.11M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $126.75M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $99.45M | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $95.87M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $119.70M | Mar 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $989.78M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $829.75M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $721.25M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $522.64M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $313.37M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $217.28M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $119.54M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $94.15M | Mar 25, 2020 |
| FY2018 | Dec 31, 2017 | $93.32M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $116.62M | Mar 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $103.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $70.01M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $62.58M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $38.51M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $17.83M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $7.21M | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | $5.31M | Mar 25, 2021 |
| FY2019 | Dec 31, 2017 | $2.55M | Mar 25, 2020 |
| FY2018 | Dec 31, 2016 | $3.08M | Mar 27, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 6, 2023 |
| FY2017 | Dec 31, 2017 | 0 | Mar 28, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 28, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 20, 2017 |
| FY2015 | Dec 31, 2014 | 1 | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 2, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 8, 2024 |
| FY2017 | Dec 31, 2017 | 0 | Mar 28, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 28, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 20, 2017 |
| FY2015 | Dec 31, 2014 | 1 | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Apr 2, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $23.61M | Apr 4, 2013 |
| FY2011 | Dec 31, 2011 | $22.78M | Mar 30, 2012 |
| FY2011 | Dec 31, 2010 | $14.37M | Mar 30, 2012 |
| FY2011 | Dec 31, 2009 | $36.78M | Mar 30, 2012 |